Cardiovascular drug shortages in Lebanon: a broken heart

Area of Science:

• Public Health
• Health Economics
• Cardiovascular Medicine

Background:

• Lebanon has experienced nearly three years of compounded crises, including economic instability, the COVID-19 pandemic, and the Beirut Port explosion.
• These crises have severely impacted the nation's healthcare system, rendering it fragile.
• A significant risk of a catastrophic public health crisis has emerged, primarily driven by cardiovascular drug shortages.

Discussion:

• The confluence of economic hardship, a global pandemic, and a major domestic disaster has created a perfect storm for Lebanon's healthcare infrastructure.
• Cardiovascular medications are essential for managing chronic conditions and acute cardiac events, making their shortage a critical public health concern.
• The long-term implications of these drug shortages could exacerbate existing health disparities and overwhelm the remaining healthcare capacity.

Key Insights:

• The Lebanese healthcare system is critically endangered by a severe shortage of cardiovascular drugs.
• Compounded national crises have directly led to this medication scarcity, threatening patient outcomes.
• Immediate and strategic interventions are required to mitigate the ongoing public health emergency.

Outlook:

• Urgent public health strategies must be implemented to secure a stable supply of essential cardiovascular medications.
• International aid and national policy reforms are crucial for rebuilding healthcare resilience.
• Without swift action, the projected long-term impact on public health in Lebanon will be devastating.